8-KA Flight Acquisition true 0001716621 0001716621 2026-03-09 2026-03-09

 

 

 

 

 

Date of Report (Date of earliest event reported): March 9, 2026

 

 

 

 

Registrant’s telephone number, including area code: (973) 691-2000

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

This Amendment No. 1 on Form 8-K/A (this “Amendment”) amends the Current Report on Form 8-K of Catheter Precision, Inc. (the “Company”) originally filed with the U.S. Securities and Exchange Commission (the “Commission”) on March 9, 2026 (the “Original Report”), which reported, among other things, the Company’s March 9, 2026 acquisition (the “Acquisition”) from Creatd, Inc. of (i) 800,200 shares of common stock of Fly Flyte, Inc., representing 80.02% of the issued and outstanding common stock of Fly Flyte, Inc., and (ii) all of the issued and outstanding membership interests of Ponderosa Air, LLC (Fly Flyte, Inc. and Ponderosa Air, LLC, collectively, “FLYTE”).

 

This Amendment is being filed solely to provide the financial statements of the business acquired required by Item 9.01(a) of Form 8-K and the pro forma financial information required by Item 9.01(b) of Form 8-K, which were not included in the Original Report in reliance on the provisions of Item 9.01(a)(4) of Form 8-K. Item 9.01(a)(4) of Form 8-K permits such financial statements and pro forma financial information to be filed by amendment to the Original Report not later than 71 calendar days after the date on which the Original Report was required to be filed with respect to the Acquisition.

 

Except as set forth herein, this Amendment does not modify or update any other disclosure contained in the Original Report. This Amendment should be read in conjunction with the Original Report and the Company’s other filings with the Commission.

 

 

(d) Exhibits.

 

 

The audited combined financial statements of FLYTE as of and for the years ended December 31, 2025 and December 31, 2024, and the related notes thereto, together with the report of WithumSmith+Brown, PC, independent registered public accounting firm, are filed as Exhibit 99.1 to this Amendment and are incorporated herein by reference.

 

 

The unaudited pro forma condensed combined financial statements of the Company giving effect to the Acquisition, consisting of an unaudited pro forma condensed combined statement of operations for the year ended December 31, 2025, and the related notes thereto, is filed as Exhibit 99.2 to this Amendment and is incorporated herein by reference.

 

 

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.